Trials / Completed
CompletedNCT05051566
A Multiple Dose Study of LY3502970 in Healthy Participants
A Multiple Dose Study in Healthy Participants to Investigate the Safety, Tolerability, and Pharmacokinetics of LY3502970
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 26 (actual)
- Sponsor
- Eli Lilly and Company · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The main purpose of this study is to assess how fast LY3502970 gets into the blood stream and how long it takes the body to remove it when administered in multiple oral doses as new formulation compared to that of reference LY3502970 formulation. Information about safety and tolerability will be collected. The study is open to healthy participants. The study is conducted in two parts and it will last up to about 6 months, inclusive of screening period.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | LY3502970 | Administered orally. |
| DRUG | Esomeprazole | Administered orally. |
Timeline
- Start date
- 2021-09-16
- Primary completion
- 2022-04-04
- Completion
- 2022-04-04
- First posted
- 2021-09-21
- Last updated
- 2022-04-26
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT05051566. Inclusion in this directory is not an endorsement.